Sökning: onr:"swepub:oai:gup.ub.gu.se/287780" >
The Long-Term Outco...
The Long-Term Outcome of Treatment for Graves' Hyperthyroidism
-
Sj?lin, G. (författare)
-
- Holmberg, Mats, 1958 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine,Karolinska Universitetssjukhuset, ANOVA, Stockholm, Sweden,Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden;Karolinska Univ Hosp, ANOVA, Stockholm, Sweden
-
- T?rring, O. (författare)
- Karolinska Institutet
-
visa fler...
-
- Byström, Kristina, 1961- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Dept. of Medicine, Örebro University Hostpital, Örebro, Sweden,Orebro Univ, Dept Med, Orebro, Sweden;Univ Hosp, Orebro, Sweden
-
- Khamisi, Selwan (författare)
- Uppsala universitet,Endokrinologi och mineralmetabolism
-
- de Laval, D. (författare)
- Blekingesjukhuset i Karlskrona, Department of Medicine, Karlskrona, Sweden,Blekinge Hosp, Dept Med, Karlskrona, Sweden
-
- Abraham-Nordling, M. (författare)
- Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Stockholm County, Sweden,Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
-
- Calissendorff, J. (författare)
- Karolinska Institutet
-
- Lantz, M. (författare)
- Lund University, Lund, Sweden,Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden;Lund Univ, Dept Clin Sci, Lund, Sweden
-
- Hallengren, B. (författare)
- Lund University, Lund, Sweden,Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden;Lund Univ, Dept Clin Sci, Lund, Sweden
-
- Nyström, Helena Filipsson, 1966 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine,Sahlgrenska Academy, Dept. of Endocrinology, Göteborg, Sweden,Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden;Sahlgrens Univ Hosp, Dept Endocrinol, Gothenburg, Sweden
-
- Wallin, Göran, 1952- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden,Orebro Univ, Fac Med & Hlth, Dept Surg, SE-70185 Orebro, Sweden;Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
-
- Sjölin, Gabriel, 1979- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Department of Surgery,Orebro Univ, Fac Med & Hlth, Dept Surg, SE-70185 Orebro, Sweden
-
visa färre...
-
(creator_code:org_t)
- Mary Ann Liebert Inc, 2019
- 2019
- Engelska.
-
Ingår i: Thyroid. - : Mary Ann Liebert Inc. - 1050-7256 .- 1557-9077. ; 29:11, s. 1545-1557
- Relaterad länk:
-
https://gupea.ub.gu....
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
https://urn.kb.se/re...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: The treatment efficacy of antithyroid drug (ATD) therapy, radioactive iodine (I-131), or surgery for Graves' hyperthyroidism is well described. However, there are a few reports on the long-term total outcome of each treatment modality regarding how many require levothyroxine supplementation, the need of thyroid ablation, or the individual patient's estimation of their recovery. Methods: We conducted a pragmatic trial to determine the effectiveness and adverse outcome in a patient cohort newly diagnosed with Graves' hyperthyroidism between 2003 and 2005 (n = 2430). The patients were invited to participate in a longitudinal study spanning 8 +/- 0.9 years (mean +/- standard deviation) after diagnosis. We were able to follow 1186 (60%) patients who had been treated with ATD, I-131, or surgery. We determined the mode of treatment, remission rate, recurrence, quality of life, demographic data, comorbidities, and lifestyle factors through questionnaires and a review of the individual's medical history records. Results: At follow-up, the remission rate after first-line treatment choice with ATD was 45.3% (351/774), with I-131 therapy 81.5% (324/264), and with surgery 96.3% (52/54). Among those patients who had a second course of ATD, 29.4% achieved remission (vs. the 45.3% after the first course of ATD). The total number of patients who had undergone ablative treatment was 64.3% (763/1186), of whom 23% (278/1186) had received surgery, 43% (505/1186) had received I-131 therapy, including 2% (20/1186) who had received both surgery and I-131. Patients who received ATD as first-line treatment and possibly additional ATD had 49.7% risk (385/774) of having undergone ablative treatment at follow-up. Levothyroxine replacement was needed in 23% (81/351) of the initially ATD treated in remission, in 77.3% (204/264) of the I-131 treated, and in 96.2% (50/52) of the surgically treated patients. Taken together after 6-10 years, and all treatment considered, normal thyroid hormone status without thyroxine supplementation was only achieved in 35.7% (423/1186) of all patients and in only 40.3% of those initially treated with ATD. The proportion of patients that did not feel fully recovered at follow-up was 25.3%. Conclusion: A patient selecting ATD therapy as the initial approach in the treatment of Graves' hyperthyroidism should be informed that they have only a 50.3% chance of ultimately avoiding ablative treatment and only a 40% chance of eventually being euthyroid without thyroid medication. Surprisingly, 1 in 4 patients did not feel fully recovered after 6-10 years. The treatment for Graves' hyperthyroidism, thus, has unexpected long-term consequences for many patients.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kirurgi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Surgery (hsv//eng)
Nyckelord
- hyperthyroidism
- Graves' disease
- antithyroid drugs
- radioiodine
- thyroidectomy
- long-term follow-up
- recurrence
- remission
- quality-of-life
- american thyroid association
- drug-induced
- agranulocytosis
- antithyroid drugs
- radioiodine treatment
- follow-up
- cancer-mortality
- disease patients
- increased risk
- management
- Endocrinology & Metabolism
- hyperthyroidism
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Thyroid
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Sj?lin, G.
-
Holmberg, Mats, ...
-
T?rring, O.
-
Byström, Kristin ...
-
Khamisi, Selwan
-
de Laval, D.
-
visa fler...
-
Abraham-Nordling ...
-
Calissendorff, J ...
-
Lantz, M.
-
Hallengren, B.
-
Nyström, Helena ...
-
Wallin, Göran, 1 ...
-
Sjölin, Gabriel, ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kirurgi
- Artiklar i publikationen
-
Thyroid
- Av lärosätet
-
Göteborgs universitet
-
Örebro universitet
-
Uppsala universitet
-
Karolinska Institutet